找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cancer Management in Man; Biological Response Paul V. Woolley Book 1989 Kluwer Academic Publishers 1989 Tumor.antibiotics.biology.bone mar

[復(fù)制鏈接]
樓主: STRI
11#
發(fā)表于 2025-3-23 13:45:25 | 只看該作者
12#
發(fā)表于 2025-3-23 14:28:13 | 只看該作者
13#
發(fā)表于 2025-3-23 18:27:06 | 只看該作者
14#
發(fā)表于 2025-3-24 00:42:11 | 只看該作者
15#
發(fā)表于 2025-3-24 05:54:31 | 只看該作者
Current Advances in BMT for Cancer Treatment,, and has recently become an alternative treatment for solid tumors, particularly lymphoma. The purpose of BMT is to repopulate the hemopoietic and lymphoid system following eradication of malignant cells with extremely high doses of chemotherapy (CT) and/or radiotherapy (RT) and, hopefully, to inhi
16#
發(fā)表于 2025-3-24 08:11:08 | 只看該作者
17#
發(fā)表于 2025-3-24 13:19:51 | 只看該作者
The Sphygmochron for Chronobiologic Blood Pressure and Heart Rate Assessment in Cancer Patients, is advocated for everyone, in order to obtain individualized reference standards in health. The assessment of a reliable chronobiologic mean (the .idline-.stimating .tatistic .f .hythm, briefly the MESOR) is particularly pertinent in the case of heart rate for patients with cancer who are treated w
18#
發(fā)表于 2025-3-24 14:50:10 | 只看該作者
https://doi.org/10.1007/3-540-45507-8 patients with cancer are not necessarily well prepared for the translation of biotherapy to the clinic. Biotherapeutic approaches are broad and involve a whole range of physiological responses inherent in cancer biology. The approaches needed to bring these biotherapeutic capabilities to the clinic
19#
發(fā)表于 2025-3-24 21:31:29 | 只看該作者
20#
發(fā)表于 2025-3-25 03:01:47 | 只看該作者
https://doi.org/10.1007/3-540-45507-8e selectively towards a tumour cell rather than towards a normal cell. Selectivity of alkylating agent attack towards tumour cells may also be increased by clinical protection measures on normal tissues (e.g., by autologous bone marrow transplantation). The development of alkylating agent use has th
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-21 20:42
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
黄陵县| 桃江县| 西乡县| 鄂托克旗| 长乐市| 浮梁县| 永嘉县| 镇原县| 原阳县| 平阴县| 聊城市| 西乌珠穆沁旗| 湟源县| 固安县| 彰化县| 腾冲县| 云浮市| 穆棱市| 镇坪县| 长沙县| 柏乡县| 扎囊县| 重庆市| 安吉县| 宁国市| 龙门县| 米泉市| 同德县| 剑阁县| 南乐县| 尤溪县| 浮山县| 灵璧县| 阜阳市| 环江| 叶城县| 长子县| 榆社县| 绥滨县| 岢岚县| 桦甸市|